Innovative therapies for challenging conditions
Sudo Biosciences develops first- and best-in-class medicines for serious neurological and immunological conditions like multiple sclerosis (MS) and other immune-mediated inflammatory conditions.
Science
Sudo is rapidly discovering and developing potentially life-changing therapies.
Leveraging and expanding on decades of scientific progress, we precisely design molecules with a focus on transforming care in some of life’s most challenging diseases.
Leading medicinal chemistry
Optimizing potency, pharmacokinetics, and selectivity for first- and best-in-class compounds
Innovative translational biology
Pursuing targets supported by human genetic data, proteomics, disease-relevant biomarkers, and integrated in vitro, in vivo and clinical translational expertise.
Patient-centered development
Integrating deep clinical expertise with a precision approach to drug design, development, and patient selection to deliver truly meaningful outcomes to patients who need them most
Pioneering the next generation of TYK2 therapeutics
Developing the next generation of of highly-differentiated TYK2 therapeutics.
Pipeline
Advancing the science of neurological and immune-mediated medicine.
We are building targeted therapies for serious neurological and immunological conditions.
Team
We are a global team of experienced drug developers.
We are a diverse team with deep experience in small molecule drug discovery and deep understanding in neurological and immunological disease states. Our highly collaborative culture is underpinned by a common drive to never settle for ‘good enough’.
